{
    "clinical_study": {
        "@rank": "134771", 
        "arm_group": [
            {
                "arm_group_label": "Arm I (thalidomide)", 
                "arm_group_type": "Experimental", 
                "description": "Patients receive oral thalidomide once daily on days 1-28."
            }, 
            {
                "arm_group_label": "Arm II (tamoxifen)", 
                "arm_group_type": "Experimental", 
                "description": "Patients receive oral tamoxifen twice daily on days 1-28."
            }
        ], 
        "brief_summary": {
            "textblock": "Randomized phase III trial to compare the effectiveness of tamoxifen with that of\n      thalidomide in treating women who have recurrent ovarian epithelial cancer, fallopian tube\n      cancer, or primary peritoneal cancer. Estrogen can stimulate the growth of some types of\n      cancer cells. Hormone therapy using tamoxifen may fight cancer by blocking the uptake of\n      estrogen. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. It\n      is not yet known whether thalidomide is more effective than tamoxifen in treating ovarian\n      epithelial cancer, fallopian tube cancer, or primary peritoneal cancer."
        }, 
        "brief_title": "Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Thalidomide 200mg orally daily with weekly escalation of 100mg to a maximum dose of 400mg until progression or additional therapy prohibited further therapy.", 
                            "title": "Grp - 1"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Tamoxifen 20mg orally for up to 12 28-day cycles until progression or adverse effect prohibited additional therapy.", 
                            "title": "Grp - 2"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "68"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "70"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "138"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "10.8", 
                                                "@value": "64.3"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "10.5", 
                                                "@value": "61.6"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "10.7", 
                                                "@value": "62.9"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "12"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "19"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "< 50 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "17"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "14"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "31"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "50-59 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "22"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "28"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "50"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "60-69 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "17"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "15"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "32"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "70-79 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "5"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "6"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "80-89 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age, Customized", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "68"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "70"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "138"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "63"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "67"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "130"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "0 - asymptomatic"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "5"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "3"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "8"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "1 - symptomatic"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gynecologic Oncology Group (GOG) Performance Status", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "58"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "59"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "117"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Ovary"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "10"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "10"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "20"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Peritoneum"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "1"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Fallopian Tube"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Primary Site of Disease", 
                            "units": "participants"
                        }
                    ]
                }, 
                "population": "Description of population is based on eligible patients.\n1 patient not included in characteristics due to ineligible primary tumor site."
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo."
            }, 
            "outcome_list": {
                "outcome": {
                    "group_list": {
                        "group": [
                            {
                                "@group_id": "O1", 
                                "description": "Thalidomide 200mg orally daily with weekly escalation of 100mg to a maximum dose of 400mg until progression or additional therapy prohibited further therapy.", 
                                "title": "Grp - 1"
                            }, 
                            {
                                "@group_id": "O2", 
                                "description": "Tamoxifen 20mg orally for up to 12 28-day cycles until progression or adverse effect prohibited additional therapy.", 
                                "title": "Grp - 2"
                            }
                        ]
                    }, 
                    "measure_list": {
                        "measure": [
                            {
                                "category_list": {
                                    "category": {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "O1", 
                                                    "@value": "68"
                                                }, 
                                                {
                                                    "@group_id": "O2", 
                                                    "@value": "70"
                                                }
                                            ]
                                        }
                                    }
                                }, 
                                "param": "Number", 
                                "title": "Number of Participants", 
                                "units": "participants"
                            }, 
                            {
                                "category_list": {
                                    "category": {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "2.7", 
                                                    "@upper_limit": "3.9", 
                                                    "@value": "3.2"
                                                }, 
                                                {
                                                    "@group_id": "O2", 
                                                    "@lower_limit": "2.7", 
                                                    "@upper_limit": "5.5", 
                                                    "@value": "4.5"
                                                }
                                            ]
                                        }
                                    }
                                }, 
                                "dispersion": "95% Confidence Interval", 
                                "param": "Median", 
                                "title": "Median Progression-free Survival", 
                                "units": "months"
                            }
                        ]
                    }, 
                    "safety_issue": "No", 
                    "time_frame": "from enrollment onto the study  until first disease progression or death due to any cause", 
                    "title": "Median Progression-free Survival", 
                    "type": "Primary"
                }
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Thalidomide 200mg orally daily with weekly escalation of 100mg to a maximum dose of 400mg until progression or additional therapy prohibited further therapy.", 
                            "title": "Grp - 1"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Tamoxifen 20mg orally twice daily for up to 12 28-day cycles until progression or adverse effect prohibited additional therapy.", 
                            "title": "Grp - 2"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "21", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Adverse Event"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "6", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "6", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Withdrawal by Subject"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Concommitant Illness/Other"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Did not start therapy"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Ineligible"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "#text": "number patients enrolled on study", 
                                                "@count": "69", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "#text": "number patients enrolled on study", 
                                                "@count": "70", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "39", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "60", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "30", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "10", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "Eligible patients had histologically confirmed ovarian, fallopian tube or primary peritoneal cancer. They had rising CA-125 that exceeded twice the upper-limit of normal, but no radiographic or physical evidence of disease following first-line chemotherapy.", 
                "recruitment_details": "Enrollment began Feb 3, 2003 and completed Jan 30, 2011. All patients were enrolled from GOG member institutions in the United States."
            }, 
            "point_of_contact": {
                "email": "mleventhal@gogstats.org", 
                "name_or_title": "Melissa Leventhal", 
                "organization": "Gynecologic Oncology Group (GOG) Statistical and Data Center", 
                "phone": "716-845-4030"
            }, 
            "reported_events": {
                "desc": "Other Adverse Events(AEs) are at least possibly related to study treatment. Due to the methods in which adverse events were collected and/or stored for this study, it is not possible to report only the Other (not including Serious) AEs in the appropriate table. Therefore, the Other AEs table includes a combined set of serious and non-serious AEs.", 
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Thalidomide 200mg orally daily with weekly escalation of 100mg to a maximum dose of 400mg until progression or additional therapy prohibited further therapy.", 
                            "title": "Grp - 1"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Tamoxifen 20mg orally for up to 12 28-day cycles until progression or adverse effect prohibited additional therapy.", 
                            "title": "Grp - 2"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "42", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "24", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "25", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Leukopenia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "21", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Neutropenia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Thrombocytopenia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "15", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Anemia"
                                        }
                                    ]
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "DVT/thrombosis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Other cardiovascular"
                                        }
                                    ]
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "24", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Endocrine"
                                    }
                                }, 
                                "title": "Endocrine disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "11", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Ocular/visual"
                                    }
                                }, 
                                "title": "Eye disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "42", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "22", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Gastrointestinal"
                                    }
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "42", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "18", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Constitutional"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "26", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "19", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Pain"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "8", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "8", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Metabolic"
                                    }
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Musculoskeletal"
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Somnolence"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "32", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Other neurologic"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "32", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Peripheral neurologic"
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Genitourinary/renal"
                                    }
                                }, 
                                "title": "Reproductive system and breast disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "11", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Pulmonary"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "22", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Dermatologic"
                                    }
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_vocab": "CTCAE (2.0)", 
                    "frequency_threshold": "5"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Neutropenia/Granulocytopenia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Edema"
                                        }
                                    ]
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Sinus tachycardia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Thrombosis/embolism"
                                        }
                                    ]
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Constipation"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Diarrhea"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Nausea"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Partial small bowel obstruction"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Fatigue"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "SGPT"
                                    }
                                }, 
                                "title": "Hepatobiliary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "67"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "69"
                                            }
                                        ], 
                                        "sub_title": "Febrile Neutropenia"
                                    }
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Neuropathy - motor"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Tremor"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "67"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "69"
                                                }
                                            ], 
                                            "sub_title": "Dizziness/lightheadedness"
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }
                        ]
                    }, 
                    "default_vocab": "CTCAE (2.0)"
                }, 
                "time_frame": "Within 30 days after stopping study treatment or any SAE that the study investigator felt was study treatment related."
            }
        }, 
        "completion_date": {
            "#text": "January 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Fallopian Tube Cancer", 
            "Primary Peritoneal Cavity Cancer", 
            "Recurrent Ovarian Epithelial Cancer", 
            "Stage III Ovarian Epithelial Cancer", 
            "Stage IV Ovarian Epithelial Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Peritoneal Neoplasms", 
                "Fallopian Tube Neoplasms", 
                "Neoplasms, Glandular and Epithelial", 
                "Ovarian Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. To compare the recurrence-free survival of women receiving tamoxifen or thalidomide for\n      epithelial ovarian cancer, cancer of the fallopian tube, or primary peritoneal carcinoma who\n      are in complete clinical remission following front-line treatment but have a high risk of\n      recurrence due to rising serum CA-125.\n\n      II. To compare the toxicities and complications of these treatments.\n\n      SECONDARY OBJECTIVES:\n\n      I. To determine whether changes in serum biomarker levels including VEGF and/or bFGF are\n      independent of the randomization treatment.\n\n      II. To determine whether serum and plasma biomarker levels including VEGF and/or bFGF are\n      associated with the duration of recurrence-free survival.\n\n      OUTLINE: This is a randomized, multicenter study. Patients are stratified according to the\n      interval between completion of front-line chemotherapy and appearance of biochemical\n      progression (6 months or less vs more than 6 months). Patients are randomized to 1 of 2\n      treatment arms.\n\n      ARM I: Patients receive oral thalidomide once daily on days 1-28.\n\n      ARM II: Patients receive oral tamoxifen twice daily on days 1-28.\n\n      In both arms, courses repeat every 28 days for up to 1 year in the absence of disease\n      progression or unacceptable toxicity. Patients may receive additional therapy beyond 1 year\n      at the investigator's discretion.\n\n      Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then\n      annually thereafter."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed stage III or IV ovarian epithelial, fallopian tube, or\n             primary peritoneal cancer that was treated with only 1 prior first-line chemotherapy\n             regimen (platinum/taxane-based)\n\n          -  Clinically and radiologically without evidence of measurable and nonmeasurable\n             disease\n\n               -  Symptomatic ascites and pleural effusions are considered nonmeasurable disease\n\n          -  Must have a biochemical recurrence\n\n               -  CA 125 must have been normal prior to or normalized during first-line therapy\n                  and then subsequently rose to exceed twice the upper limit of normal\n\n               -  Patients entering study with a CA 125 level less than 100 U/mL must be confirmed\n                  a second time within a period of not more than 4 weeks\n\n               -  Patients with a CA 125 level of at least 100 U/mL may be entered without\n                  confirmatory measurement\n\n          -  Ineligible for a higher priority Gynecologic Oncology Group protocol (if one exists)\n\n          -  No history of brain metastases\n\n          -  Performance status - GOG 0-1\n\n          -  Absolute neutrophil count at least 1,500/mm^3\n\n          -  Platelet count at least 100,000/mm^3\n\n          -  Bilirubin no greater than 1.5 times upper limit of normal (ULN)\n\n          -  SGOT no greater than 2.5 times ULN\n\n          -  Alkaline phosphatase no greater than 2.5 times ULN\n\n          -  Creatinine no greater than 1.5 times ULN\n\n          -  Creatinine clearance at least 60 mL/min\n\n          -  No history of deep venous thrombosis\n\n          -  No prior cerebrovascular accident\n\n          -  No history of pulmonary embolism\n\n          -  No significant infection\n\n          -  No grade 2 or greater sensory or motor neuropathy\n\n          -  No other malignancy within the past 5 years except nonmelanoma skin cancer or\n             carcinoma in situ\n\n          -  Not pregnant or nursing\n\n          -  Negative pregnancy test\n\n          -  Fertile patients must use at least 1 highly active method and at least 1 additional\n             effective method of contraception for 4 weeks before, during, and for 4 weeks after\n             study participation\n\n          -  No prior immunotherapy (e.g., interleukins)\n\n          -  No prior biological response modifiers (e.g., monoclonal antibodies)\n\n          -  No prior antiangiogenic agents (e.g., carbonic anhydrase inhibitors)\n\n          -  At least 3 weeks since prior anticancer chemotherapy and recovered\n\n          -  No prior or concurrent tamoxifen or other selective estrogen receptor modulators\n\n          -  At least 4 weeks since prior and no concurrent hormones (e.g., estrogen or\n             progesterone)\n\n          -  At least 3 weeks since prior anticancer radiotherapy and recovered\n\n          -  At least 3 weeks since prior anticancer surgery and recovered\n\n          -  Prior second-look surgery without cytoreduction allowed\n\n          -  At least 3 weeks since other prior anticancer therapy and recovered\n\n          -  No prior interval cytoreduction\n\n          -  No concurrent full-dose therapeutic anticoagulation\n\n          -  No concurrent antiseizure medications for seizure disorder\n\n          -  No concurrent bisphosphonates (e.g., zoledronate)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "139", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 8, 2002", 
        "firstreceived_results_date": "July 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00041080", 
            "org_study_id": "NCI-2012-02475", 
            "secondary_id": [
                "NCI-2012-02475", 
                "CDR0000069441", 
                "GOG-0198", 
                "GOG-0198", 
                "U10CA027469"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Arm II (tamoxifen)", 
                "description": "Given orally", 
                "intervention_name": "tamoxifen citrate", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Nolvadex", 
                    "TAM", 
                    "tamoxifen", 
                    "TMX"
                ]
            }, 
            {
                "arm_group_label": "Arm I (thalidomide)", 
                "description": "Given orally", 
                "intervention_name": "thalidomide", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Kevadon", 
                    "Synovir", 
                    "THAL", 
                    "Thalomid"
                ]
            }, 
            {
                "arm_group_label": [
                    "Arm I (thalidomide)", 
                    "Arm II (tamoxifen)"
                ], 
                "description": "Correlative studies", 
                "intervention_name": "laboratory biomarker analysis", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Tamoxifen", 
                "Thalidomide"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19103"
                }, 
                "name": "Gynecologic Oncology Group"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Study Of Tamoxifen Versus Thalidomide (NSC# 66847) In Patients With Biochemical-Recurrence-Only Epithelial Ovarian Cancer, Cancer Of The Fallopian Tube, And Primary Peritoneal Carcinoma After First Line Chemotherapy", 
        "overall_official": {
            "affiliation": "Gynecologic Oncology Group", 
            "last_name": "Jean Hurteau", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Median Progression-free Survival", 
            "safety_issue": "No", 
            "time_frame": "from enrollment onto the study  until first disease progression or death due to any cause"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00041080"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "February 2003", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }, 
    "geocoordinates": {
        "Gynecologic Oncology Group": "39.952 -75.164"
    }
}